JP2022539753A5 - - Google Patents

Info

Publication number
JP2022539753A5
JP2022539753A5 JP2021577332A JP2021577332A JP2022539753A5 JP 2022539753 A5 JP2022539753 A5 JP 2022539753A5 JP 2021577332 A JP2021577332 A JP 2021577332A JP 2021577332 A JP2021577332 A JP 2021577332A JP 2022539753 A5 JP2022539753 A5 JP 2022539753A5
Authority
JP
Japan
Prior art keywords
btn2a1
cells
antagonist
agonist
btn3a1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021577332A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022539753A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2020/050662 external-priority patent/WO2020257871A1/en
Publication of JP2022539753A publication Critical patent/JP2022539753A/ja
Publication of JP2022539753A5 publication Critical patent/JP2022539753A5/ja
Priority to JP2025013162A priority Critical patent/JP2025090566A/ja
Pending legal-status Critical Current

Links

JP2021577332A 2019-06-28 2020-06-26 ガンマデルタｔ細胞を阻害する、または活性化させる方法 Pending JP2022539753A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025013162A JP2025090566A (ja) 2019-06-28 2025-01-29 ガンマデルタｔ細胞を阻害する、または活性化させる方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AU2019902308A AU2019902308A0 (en) 2019-06-28 Method of inhibiting or activating gamma delta t cells
AU2019902308 2019-06-28
AU2019904771A AU2019904771A0 (en) 2019-12-17 Method of inhibiting or activating gamma delta t cells
AU2019904773 2019-12-17
AU2019904771 2019-12-17
AU2019904773A AU2019904773A0 (en) 2019-12-17 Method of inhibiting or activating gamma delta t cells
PCT/AU2020/050662 WO2020257871A1 (en) 2019-06-28 2020-06-26 Method of inhibiting or activating gamma delta t cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025013162A Division JP2025090566A (ja) 2019-06-28 2025-01-29 ガンマデルタｔ細胞を阻害する、または活性化させる方法

Publications (2)

Publication Number Publication Date
JP2022539753A JP2022539753A (ja) 2022-09-13
JP2022539753A5 true JP2022539753A5 (https=) 2023-07-04

Family

ID=74059614

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021577332A Pending JP2022539753A (ja) 2019-06-28 2020-06-26 ガンマデルタｔ細胞を阻害する、または活性化させる方法
JP2025013162A Pending JP2025090566A (ja) 2019-06-28 2025-01-29 ガンマデルタｔ細胞を阻害する、または活性化させる方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025013162A Pending JP2025090566A (ja) 2019-06-28 2025-01-29 ガンマデルタｔ細胞を阻害する、または活性化させる方法

Country Status (8)

Country Link
US (1) US20220273713A1 (https=)
EP (1) EP3990496A4 (https=)
JP (2) JP2022539753A (https=)
KR (1) KR20220100567A (https=)
CN (1) CN114746445A (https=)
AU (1) AU2020301813A1 (https=)
CA (1) CA3144755A1 (https=)
WO (1) WO2020257871A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022109110A1 (en) * 2020-11-19 2022-05-27 Shattuck Labs, Inc. Methods of identifying gamma delta t cell-modulating agents
US20250179144A1 (en) * 2021-12-09 2025-06-05 The University Of Melbourne Modified Butyrophilin and Butyrophilin Complexes
EP4638472A1 (en) * 2022-12-19 2025-10-29 UMC Utrecht Holding B.V. Btn2a1 binding peptide
WO2025031287A1 (zh) * 2023-08-04 2025-02-13 江苏恒瑞医药股份有限公司 Btn3a结合蛋白及其医药用途
WO2025045192A1 (en) * 2023-08-31 2025-03-06 Biosion Inc. Antibodies binding btn3a1 and uses thereof
WO2025064752A1 (en) * 2023-09-20 2025-03-27 La Jolla Institute For Immunology Human anti-sars-cov-2 spike (s) antibodies
WO2025082418A1 (zh) * 2023-10-18 2025-04-24 苏州沙砾生物科技有限公司 一种鉴定靶标的方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0717101D0 (en) * 2007-09-03 2007-10-10 Cambridge Entpr Ltd Tumour marker
JP2016540046A (ja) * 2013-11-29 2016-12-22 シーエスエル、リミテッド ガンの治療方法
EP3827838B1 (en) * 2015-12-16 2023-06-07 The Walter and Eliza Hall Institute of Medical Research Inhibition of cytokine-induced sh2 protein in nk cells
WO2017149394A1 (en) * 2016-02-29 2017-09-08 Ose Immunotherapeutics Non-antagonistic antibodies directed against the alpha chain of the il7 receptor extracellular domain and use thereof in cancer treatment
KR102764182B1 (ko) * 2017-09-21 2025-02-07 임체크 테라퓨틱스 Ｂｔｎ２에 대해 특이성을 갖는 항체 및 이의 용도

Similar Documents

Publication Publication Date Title
JP2022539753A5 (https=)
KR102100419B1 (ko) 항-pd1 항체 및 이의 치료 및 진단 용도
RU2019128134A (ru) Антитело против gprc5d и молекула, содержащая антитело
JP2022515318A5 (https=)
TWI854953B (zh) 抗ｃｄ３抗體及含有該抗體的分子、及其製造方法
RU2014127438A (ru) Антитела против человеческого csf-1r и их применения
JP2021527431A5 (https=)
RU2017137872A (ru) Композиции для ингибирования masp-2-зависимой активации комплемента
JP2021534762A5 (https=)
JP2020510422A5 (https=)
JP2022521705A5 (https=)
JP2012525829A5 (https=)
JP2019536430A5 (https=)
JP2014158469A5 (https=)
JP2012500020A5 (https=)
RU2010100638A (ru) Композиции и способы лечения, направленные против cd20
RU2017122014A (ru) Антитела к c10orf54 и их применения
RU2012142231A (ru) Антитела против csf-1r человека и их применение
JP2017536341A5 (https=)
JP2015163068A5 (https=)
JP2014509510A5 (https=)
JP2014532074A5 (https=)
RU2016100892A (ru) Антитела против tweakr и их применение
RU2009123409A (ru) Новые антипролиферативные антитела
HRP20140502T1 (hr) Humanizirana anti-cxcr4 antitijela za lijeäśenje karcinoma